TIGECYCLINE MYLAN

50MG INF PLV SOL 10

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 23.08.2019
Interruption of marketing 11.03.2019 0026127
Capacity/distribution reasons 15.04.2019
Placing on the market 07.11.2018

All reports are available in the Overview.

Back to list